Bringing the fundamentals into focus…
Back to Vanda Pharmaceuticals Inc.
How Vanda Pharmaceuticals Inc. stacks up
VNDA · against 233 other Healthcare companies of similar size
Growth
26/ 100
Below the middle of the pack.
Ranked #148 of 234 · scores higher than 36% of peers
Bars: peers in each 10-point band of the growth score19 peers with a growth score of 20–29, including VNDA · Click a bar to see the companies
Why growth scores 26?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- slower revenue growth over three years: weaker than 79% of peers. 3-year revenue growth: -3.3% vs peer median 5.8%
- Revenue growth is close to the peer norm. Revenue growth: 6.0% vs peer median 6.1%
Metric by metric
Position: dot = VNDA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VNDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 247 reported | 6.0% | 3.0% | 57% | 33% | |
| Earnings per share growthHigher is better · 99 reported | Not reported | 6.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 227 reported | -3.3% | 3.7% | 32% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around VNDA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 1 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 433M USD | 99 | 81 | |
| 5 | 5.7B TWD (≈$177M) | 98 | 65 | |
| 145 | 1.6B HKD (≈$209M) | 29 | 54 | |
| 145 | 318M USD | 29 | 26 | |
| 147 | 3.1B CNY (≈$440M) | 27 | 59 | |
| 148 | 1.4B HKD (≈$180M) | 26 | 61 | |
| 148 | 227M USD | 26 | 24 | |
| 150 | 172.4B KRW (≈$124M) | 24 | 26 | |
| 150 | 2.3B CNY (≈$318M) | 24 | 68 | |
| 150 | 344M USD | 24 | 54 | |
| 153 | 2.0B CNY (≈$286M) | 23 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score